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Abstract
Background: Eicosanoids mediate initiation and resolution of inflammation. Our aim was evaluating the effects of
training, exercise and docosahexaenoic (DHA) supplementation on plasma eicosanoids levels and peripheral blood
mononuclear cells (PBMCs) eicosanoids production.
Methods: Fifteen male footballers were distributed to placebo and experimental groups. Experimental group
consumed DHA-enriched beverage (1.16 g DHA/day) for 8 weeks, placebo group consumed a placebo beverage.
Blood samples were taken before and after the nutritional intervention in basal conditions and 2 h after acute
exercise.
Results: Training increased basal Prostaglandin E1 (PGE1) plasma levels and PBMCs cyclooxygenase 2 (COX-2)
protein levels in both groups, but COX-1 protein levels only in the experimental group. Acute exercise
increased plasma PGE2 and PBMCs active NFκβ levels. Lipopolysaccharide (LPS)-stimulated PBMCs increases
eicosanoids production (PGE1, PGE2, RvD1) in both groups and increased LPS-stimulated PBMCs active NFκβ.
DHA supplementation increased COX-2 levels but decreased LPS-stimulated PBMCs PGE1 and PGE2 production.
Neither DHA supplementation nor acute exercise altered the expression of NFκβ, COX-2, 15-LOX2, 5-LOX, or
IL-1β genes in PBMCs.
Conclusions: The increase of PGE1 plasma levels after training promoted systemic anti-inflammatory and vasodilator
environment. Exercise and DHA supplementation acted synergistically by increasing plasma PGE2 with anti-inflammatory
effects. Exercise primed PBMCs to enhance PGE1, PGE2 and RvD1 production in response to LPS.
Trial registration: The project was registered at ClinicalTrial.gov (NCT02177383).
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Background
The practice of regular physical exercise has many health
benefits, reducing the risk of suffering from several diseases
such as cardiovascular disease, cancer, diabetes and osteo-
porosis [25]. Exercise exerts anti-inflammatory effects me-
diated by reduction of visceral fat mass [25], but may also
be related to decreased levels of Toll-Like Receptors (TLRs)
in monocytes [12] and to muscle production of bioactive
compounds during contraction [29]. Each bout of acute
exercise results in alterations in the pro/anti-inflammatory
cytokine balance [6, 7, 36]. Moreover, the increased produc-
tion of anti-inflammatory cytokines during exercise coun-
teracts the production of pro-inflammatory cytokines
associated to muscle damage, resulting in the instauration
of an anti-inflammatory environment [28]. In addition,
acute exercise alters the number and function of circulating
immune cells [36], which are primed for their extravasation
into tissues after exercise, thereby contributing to repair the
damaged tissue [19].
Polyunsaturated omega-3 fatty acids (ω-3 PUFA) con-
tribute to regulate inflammation associated with chronic
diseases including obesity, arthritis and atherosclerosis
[4]. The anti-inflammatory effects of ω-3 PUFA are
evidenced by the inhibition of endotoxin-stimulated pro-
duction of IL6 and IL8 in endothelial cells [18]. However,
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ω-3 PUFA diet supplementation does not affect plasma
cytokine response to strenuous exercise, which produces
muscle damage and inflammation [6, 7, 36]. The anti-
inflammatory effects of ω-3 PUFA are mediated by their
participation in the regulation of the nuclear factor κβ
(NFκβ) signalling pathway and/or peroxisome proliferator-
activated receptor (PPARγ) [3, 13]. The expression of pro-
inflammatory genes via the NFκβ signalling pathway
decreases after twelve weeks of ω-3 PUFA diet supplemen-
tation [31]. ω-3 PUFA diet supplementation also alters the
function of immune cells [3], modulating chemotaxis and
leukotriene generation in neutrophils by reducing arachi-
donic acid (AA) concentrations [20]. Eicosapentaenoic acid
and docosahexaenoic acid (DHA) can compete with
AA as a substrate for cyclooxygenase 2 (COX-2) and 5-
lipoxygenase (5-LOX), thus reducing the production of
inflammatory mediators derived from AA. This process
plays a critical role in the initial inflammatory response
[6, 7, 37]. Prostaglandins (PGs) mediators arising from
the COX-1 and COX-2 cascade from AA or its precur-
sors are central to vascular responses, permitting neu-
trophils and monocytes to leave post capillary venules.
PGs also play a role in the regulation of muscle protein
metabolism [2], vasodilation, human skeletal muscle
microcirculation, febrile and inflammatory responses
[39], and initiation and timely resolution of inflamma-
tion [32]. Prostaglandin E1 (PGE1) and prostaglandin
E2 (PGE2) are potent vasodilators which account for
the increased blood flow in inflamed areas but PGE1
also regulates neutrophil function by reducing neutrophil
activation [41]. Because of these vasodilator and immune
properties, PGs are used as treatment for diseases derived
from ischemia-reperfusion, such as arterial occlusive dis-
ease and venous ulcers [11, 22, 41].
The response of PGs to exercise has not been clearly
established yet. Skeletal muscle produces PGs in re-
sponse to muscular work, and this production is blocked
by the intake of COX inhibitors, [22, 38]. Plasma PGE2
concentration increases in response to exercise or to
muscle damage [1]. In other words, exercise increases
PGE2 production as part of the inflammatory response,
triggered by micro trauma occurring in skeletal muscles,
[1]. In addition, PGE2 synthesis by infiltrating macro-
phages in the inflamed muscle increases 24–48 h after
an exercise session [40]. It is also noticeable that downhill
running for 45 min at 75 % VO2max increases circulating
monocyte production of PGE2 [5]. The effects of PGE2 can
be described as pro-inflammatory or anti-inflammatory
depending on location, since PGE2 enhances LTB4-
mediated neutrophil extravasation and tissue injury, but
it can also inhibit the NFκβ signalling pathway in mac-
rophages [21]. This inhibition plays a critical function
in the initiation of resolution via lipid mediator class
switching [32].
A new family of lipid mediators produced from the
oxidation of ω-3 PUFA including resolvins (Rvs), mare-
sins and protectins has been described as pro-resolving
mediators of inflammation [33]. The synthesis of these
products involves COX and LOX pathways from DHA
and EPA [33]. Rvs have been reported to reduce inflam-
mation in chronic inflammatory diseases. Specifically,
RvE1 and RvD1 inhibit trans-endothelial migration of
neutrophils, preventing the infiltration of neutrophils
into sites of inflammation, and RvD1 also inhibits IL1β
production [34]. Plasma RvE1 and RvD1 have also been
demonstrated to increase after acute exercise [22] but
the participation of these lipid mediators in the anti-
inflammatory effects of acute exercise has not been
studied.
The aim of this study was to evaluate the effects of
regular training and DHA diet supplementation on
plasma lipid mediators. The effects of DHA diet supple-
mentation and acute exercise on plasma prostaglandins
and on PBMC capabilities to produce cytokines, prosta-
glandins and pro-resolving mediators in response to
lipopolysaccharide (LPS) stimulation were also analysed.
Methods
Subjects and anthropometric characteristics
Fifteen male soccer players from the Real Mallorca B
team volunteered to participate in this study, 6 subjects
took one liter of a placebo beverage five times a week
and the other 9 an experimental beverage rich in DHA,
over a period of 8 weeks. The subjects and study design
was the same described previously [6, 7, 23, 24]. At the
beginning of the study, 22 subjects were recruited, but 6
of them left the football team during the experimental
time and joined the first and professional team and one
broke the anterior cruciate ligament of the knee. All
subjects gave their written informed consent after an
explanation of the experimental procedures and before
commencement of the study. The study protocol was in
accordance with the Declaration of Helsinki for research
on human subjects and was approved by the Ethical
Committee of Clinical Investigation of the CAIB (Palma
de Mallorca, Balearic Islands, Spain). The project was
registered at ClinicalTrial.gov (NCT02177383).
Height was determined using a mobile anthropometer
(Kawe 44444, Asperg, Germany) to the nearest milli-
metre, with the subject’s head in the Frankfurt plane.
Body weight was determined to the nearest 100 g using
a digital scale (Tefal, sc9210, Rumilly, France). The sub-
jects were weighed in bare feet and light underwear, and
the mean of three measurements was used [6, 7, 23, 24].
Body mass index was calculated using the following
equation: [BMI =mass (kg)/squared height (m)]. Partici-
pants in the study were 19.7 ± 0.4 years old, 76.5 ±
2.5 kg weight, and 179.5 ± 2.5 cm height. The waist
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circumference was 78.4 ± 0.9 cm, hip circumference was
97.4 ± 1.2 cm, waist-hip ratio (WHR) was 0.81 ± 0.01. The
systolic blood pressure 119.5 ± 6.5 mmHg, and 61.7 ±
4.7 mmHg for the diastolic blood pressure. The Body
Mass Index (BMI) was 23.7 ± 0.55, kg/m2. The soccer
players had 92.6 ± 0.2 % fat free mass. The VO2max deter-
mined following the test of Leger-Boucher, was 61.4 ±
1.35 mL/kg min. There were no significant differences
between groups in the anthropometric characteristics
of players.
DHA supplementation
DHA was administered to the athletes using an almond-
based isotonic beverage. Both placebo and supplemented
beverages were made up of 3.0 % almond and 0.8 % su-
crose and the rest was water, flavour, and added oils and
vitamin E. Moreover, the placebo drink contained 0.8 %
refined olive oil whereas the experimental drink contained
0.6 % refined olive oil and 0.2 % wt % DHA-S (DSM,
Columbia, USA). The two almond beverages were manu-
factured by Liquats Vegetals S.A. (Girona, Spain) following
an industrial process. Two beverages were made-up by:
cinnamon and lemon natural flavours, sucrose, vitamin E,
and the respective oil for the experimental (olive oil plus
DHA-S) or placebo (olive oil) drink [6, 7, 23, 24]. Finally,
the beverages were sterilized and packed. Both types of
beverages were identical in taste and visual appearance.
Beverages fatty acid composition was determined follow-
ing the same procedure previously described [23, 24]. The
experimental beverage had a significantly greater content
of C20:3 (0.640 mg/100 ml of beverage), C22:0 (2.57 mg/
100 ml of beverage), C22:5 (56.1 mg/100 ml of beverage)
and C22:6n3 (114 mg/100 ml of beverage) compared to
the placebo beverage, in which these fatty acids were not
present. No significant differences between beverages were
evidenced in vitamin E content (41.6 mg/L of beverage n
placebo drink, and 45.7 mg/L of beverage in the experi-
mental drink).
Dietary intake and nutritional intervention
Dietary habits of subjects were assessed using a 7-day
dietary record questionnaire completed at the beginning
of the study and in the week before the exercise test as
previously described [6, 7, 23, 24]. A qualified dietician
verified and quantified the food records. All food items
consumed were transformed into nutrients using a spe-
cial computerized program based on the European and
Spanish food composition tables [6, 7, 23, 24]. DHA in-
take in the placebo group from the diet was 109 ±
40.7 mg/day, and DHA intake in the experimental group
was 1209 ± 40.7 mg/day. The five times a week intake of
1 L of the supplemented beverage supposed a daily in-
take of about 1.14 g of DHA additional to the basal
DHA intake through the diet in the experimental group,
whereas the placebo only took up DHA from the diet.
This nutritional intervention with the respective bever-
ages for eight weeks is reflected in the erythrocytes fatty
acid composition [23, 24].
Experimental procedure
For each subject two blood samples were taken at the
end of the nutritional intervention, in basal conditions
and after performing a soccer training session. The exer-
cise consisted in a 2 h of habitual physical training ses-
sion. After a 15 min warm-up, the players performed the
Leger Boucher test. After that, players practiced a recov-
ery exercise of control-passing for 15 min. The main
body of the training session was characterized by small-
sided games. Briefly, the first exercise consists of 5 vs 5
possession exercise in an area of 20 x15 m (4 repetitions
of 5 min with 30 s of recovery between repetitions); the
second was a 6 vs 6 possession exercise in an area of 30
x 20 m (3 repetitions of 6 min with 1 min of recovery
between repetitions), and finally, the players played a
soccer match 5 vs 5 in 30 x 40 m for 20 min. The train-
ing session was designed to perform exercise intensity at
more than 70 % VO2max over 50 % duration of the
session in order to induce an oxidative stress situation
[35]. These conditions were followed by all participants
in the study.
Blood samples used for analysis were collected from
the same athletes, at the same time, using the same exer-
cise protocols as previous described [6, 7, 23, 24]. The
blood samples used to measure prostaglandins and Rvs
plasma levels, cytokine production and expression were
the same as those previously used [6, 7].
PBMCs purification
Blood samples were centrifuged at 900 g at 4 °C for
30 min and the plasma was keep. The erythrocyte phase
at the bottom was washed with PBS, centrifuged as
above and finally erythrocytes were reconstituted with
distilled water. The PBMCs fraction was purified from
whole blood following an adaptation of the method pre-
viously described [6, 7] using Ficoll-Paque PLUS reagent
(GE Healthcare®). An aliquot of PBMCs was used for
LPS incubation.
PBMC incubation with LPS
Incubations of PBMCs were performed in RPMI 1640
culture media containing 2 mM l-glutamine in the pres-
ence of the bacterial stimuli LPS. PBMCs obtained after
8-week beverage supplementation in basal conditions
and after exercise were diluted with RPMI 1640 culture
media to 2x106 cells/ml and activated by addition of LPS
from Escherichia coli (1 μg/ml). Samples were incubated
in polypropylene tubes at 37 °C for 2 h. In a parallel
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experiment, an aliquot of PBMCs obtained after exercise
were activated with LPS and incubated at either 37 °C or
39.5 °C for 2 h. Then, after shaking, the cells from both
experiments were pelleted by centrifugation (900 g, 5 min)
and the cell-free supernatants were stored at -70 °C for
cytokine determinations.
Active NFκβ determination
An isolated suspension of PBMCs was subjected to
whole-cell protein extraction for the determination of
NFκβ p50 activation, which was performed using the
ELISA method TransAM NF-kB p50 Chemi according to
the manufacturer’s instructions (Active Motif®). Briefly,
the primary antibody used to detect NFκβ recognizes an
epitope on p50 that is accessible only when NFκβ is acti-
vated and bound to its DNA target.
Cytokine and lipid mediator determination
IL1β and MCP1 were measured in culture medium
supernatant using ELISA kits. IL1β and MCP1 kits
(RayBio®); intra-assay and inter-assay reproducibility
for both kits were lower than 10 % and 12 %.
PGE1 and PGE2 were measured in plasma and in cul-
ture medium supernatant using ELISA kits (Enzo Life
Sciences®). Intra-assay and inter-assay reproducibility for
PGE1 were lower than 10 % and 12 %, respectively, while
intra-assay and inter-assay reproducibility for PGE2 were
lower than 6 % in both cases.
RvD1 concentration in culture medium supernatants
was determined using an RvD1 EIA Kit (Cayman®), fol-
lowing the instructions manual. Intra-assay reproducibil-
ity was 10 %.
PBMCs RNA extraction and real time PCR assay
COX-2, NFκβ, 15-LOX2, IL-1β, 5-LOX mRNA levels
were determined by multiplex real time PCR based on
incorporation of a fluorescent reporter dye and using
human 18S rRNA as reference. For this purpose, total
RNA was isolated from PBMCs by Tripure extraction
(Roche Diagnostics®). RNA (1 μg) from each sample was
reverse transcribed using 50 U of Expand Reverse Tran-
scriptase (Roche Diagnostics, Germany) and 20 pmol
oligo for 60 min at 37 °C in a 10 μL final volume,
according to manufacturer instructions. The resulting
cDNA (2.5 μL) was amplified using the Light-Cycler
FastStart DNA MasterPLUS SYBR Green I kit (Roche
Diagnostics®). Amplification was performed at 55 °C and
45 cycles. The relative quantification was performed by
standard calculations considering 2(-ΔΔCt). Inflamma-
tory gene expression levels before and after the session
were normalized to the invariant control 18S rRNA.
mRNA levels at the beginning of the stage were arbitrar-
ily referred to as 1. Primers used are 18S forward (Fw):
5′-ATG TGA AGT CAC TGT GCC AG-3′ and Reverse:
5′-GTG TAA TCC GTC TCC ACA GA-3′ annealing
temperature 60 °C; COX-2 Fw: 5-TTG CTG GCA GGG
TTG CTG GTG GTA-3′, and Rv: 5′-CAT CTG CCT
GCT CTG GTC AAT GGA A-3′ annealing temperature
67 °C; NFκβ, Fw: 5′-AAA CAC TGT GAG GAT GGG
ATC TG-3′ Rv: 5′-CGA AGC CGA CCA CCA TGT-3′
annealing temperature 60 °C; 15-LOX2, Fw: 5′-GCA TCC
ACT GAT TGG ACC TT-3′ and Rv: 5′-GCT GGC CTT
GAA CTT CTG AC-3′ annealing temperature 61 °C; IL-
1β Fw: 5′-GGA CAG GAT ATG GAG CAA CA-3′, and
Rv: 5′-GGC AGA CTC AAATTC CAG CT -3′ annealing
temperature 58 °C; 5-LOX, Fw: 5′-GGG CAT GGA GAG
CAA AGA AG-3′ and Rv: 5′-ACC TCG GCC GTG AAC
GT-3′ annealing temperature 59 °C.
SDS-polyacrylamide gel electrophoresis and western blot
analysis
Cells were lysed with 250 μL of RIPA buffer [250 mM
Tris/HCl, pH 8.0, 4.4 % NaCl, 5 % IGEPAL®, 2.5 %
deoxycholic acid, 0.5 % sodium dodecylsulfate (SDS)].
20 μg of proteins of total cell extract was loaded on
12 % polyacrylamide gel, and were separated by size
using SDS polyacrylamide gel. Following electrophoresis,
samples were transferred onto a nitrocellulose mem-
brane and incubated with a primary monoclonal anti-
body anti-COX-1 (1:1000) and anti-COX-2 (1:1000)
(Cayman®).
Blots were then incubated with a secondary peroxidase-
conjugated antibody (1:10,000), and the primary antibody
was performed. Protein bands were visualized by Immun-
Star® Western C® Kit reagent (Bio-Rad Laboratories)
Western blotting detection systems. The chemilumines-
cence signal was captured with a Chemidoc XRS densi-
tometer (Bio-Rad Laboratories®) and analyzed with
Quantity One-1D Software (Bio-Rad Laboratories®).
Statistical analysis
Statistical analysis was carried out using Statistical
Package for Social Sciences (SPSS v.15.0 for Windows).
Results are expressed as mean ± SEM. and P < 0.05
was considered statistically significant. A Kolmogorov-
Smirnov test was applied to assess the normal distri-
bution of the data. The statistical significance of the
data was assessed by two-way analysis of variance
(ANOVA). The statistical factors analysed were bever-
age supplementation (S), acute exercise (E), training
season (T) and LPS stimulation (A). The data sets
with a significant SxE, SxT, ExA, SxA and SxAxE in-
teractions were tested by the ANOVA one-way test in
order to identify groups who were different. When
significant effects of S, E, T or A factor were found, a
Student’s t test for paired data was used to determine
the differences between the groups involved.
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Results
Normality of the data was assessed using the Kolmogorov-
Smirnov test and the dependent variable was normally
distributed in each group that was compared in the
ANOVA test.
Regular training and DHA diet supplementation effects
Training season and DHA diet supplementation signifi-
cantly influenced PBMC counts. The training season
increased circulating PBMCs from 2.79 ± 0.16x103 to
3.34 ± 0.15x103 cells/μL in the placebo group, and from
3.23 ± 0.29x103 to 3.99 ± 0.34x103cells/μL in the experi-
mental group. This increase only was significantly in
the experimental group.
DHA diet supplementation for 8 weeks caused a vari-
ation in the DHA percentage on erythrocytes membrane
(results not shown). The initial percentage of DHA re-
spect to erythrocyte total fatty acid in placebo group
(7.37 ± 0.27 %) was maintained after the diet supplemen-
tation with placebo beverage (8.40 ± 0.41 %), whereas the
initial percentage of DHA in experimental group (7.93 ±
0.54 %) was significantly increased (10.8 ± 0.50 %) to
attain a significantly higher content than the placebo
group.
Regular training of soccer players for 8 weeks signifi-
cantly influenced the basal plasma levels of PGE1 whereas
DHA diet supplementation significantly changed the
basal plasma levels of PGE2 (Fig. 1). Plasma PGE1
significantly increased after 8 weeks of training in
Fig. 1 Effects of acute exercise, DHA diet supplementation and training season on PGE1 and PGE2 plasma levels. Statistical analysis: Two-way
ANOVA, p < 0.05. (T) Significant effect of Training season, (S) Significant effect of Supplementation, (E) Significant effect of Acute Exercise, (ExT)
Significant interaction between both factors. One-way ANOVA, p < 0.05. (*) Significant difference between Initial and Final, (#). Significant differences
between Placebo and Experimental groups, ($) Significant differences between the Basal and Post-exercise. When interaction exists between different
groups, different letters reveal significant differences. Results are the mean ± SEM
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both placebo and experimental groups, while plasma
PGE2 maintained the initial basal levels. No signifi-
cant differences were reported in PGE2 at the begin-
ning of the intervention although its levels in the
experimental group were lower than in the placebo.
This trend was magnified after 8 weeks training
reporting significant differences due to DHA diet
supplementation.
Regular training but not DHA diet supplementation
significantly influenced COX-1 and COX-2 protein levels
in PBMCs (Fig. 2). Eight weeks of regular training sig-
nificantly increased COX-1 and COX-2 protein levels in
experimental group but not in placebo group.
Acute exercise and DHA diet supplementation effects
Acute exercise did not influence PBMC counts, main-
taining the basal values both in placebo and experi-
mental groups (Placebo group: 3.34 ± 0.15 in basal
conditions, 3.19 ± 0.15 after acute exercise; Experimen-
tal group: 3.99 ± 0.34 in basal conditions, 3.13 ± 0.16
after acute exercise, all PBMC results are expressed as
103cells/μL).
The effects of acute exercise and DHA diet supple-
mentation on PGE1 and PGE2 plasma levels are shown
in Fig. 1. Acute exercise and DHA diet supplementation
did not influence PGE1 plasma levels, whereas a statisti-
cally significant interaction between acute exercise and
Fig. 2 Effects of acute exercise, DHA diet supplementation and training season on COX1 and COX2 protein levels. Statistical analysis: Two-way
ANOVA, p < 0.05. (T) Significant effect of Training season, (S) Significant effect of Supplementation, (E) Significant effect of Acute Exercise, (ExT)
Significant interaction between both factors. One-way ANOVA, p < 0.05. (*) Significant difference between Initial and Final, (#). Significant differences
between Placebo and Experimental groups, ($) Significant differences between the Basal and Post-exercise. When interaction exists between different
groups, different letters reveal significant differences. Results are the mean ± SEM
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DHA diet supplementation was reported in plasma
levels of PGE2. The experimental group showed signifi-
cantly increased levels (about 2.4 times) of plasma PGE2
after acute exercise, whereas the placebo group main-
tained basal levels. This response resulted in higher
PGE2 plasma levels in the experimental group (about 1.6
times) with respect to the placebo one.
The effects of DHA diet supplementation and acute
exercise on the production rates of lipid mediators by
LPS-stimulated PBMCs at 39.5 °C were also evaluated
(Table 1). Acute exercise caused a significant increase in
PGE1 and PGE2 production by LPS-stimulated PBMCs
both in placebo and experimental groups. DHA diet
supplementation significantly ameliorated the increase in
both PGs production rate by LPS-stimulated PBMCs.
The RvD1 production rate by LPS-stimulated PBMCs at
39.5 °C increased after acute exercise in both groups,
but the increase was only significant (about 2.2 times) in
the experimental group,
The effects of LPS-stimulation of PBMCs, acute exer-
cise, and DHA diet supplementation on PBMC cytokine
production are reported in Table 2. LPS-stimulation of
PBMCs significantly increased IL1β basal production
rate in both placebo (about 2.2 times) and experimental
(about 1.8 times) groups, without any effect by DHA diet
supplementation or acute exercise. No significant effects
induced by LPS-stimulation or DHA diet supplementa-
tion were observed in MCP1 production rate. However,
acute exercise significantly increased the MCP1 produc-
tion rate by non-stimulated PBMCs, mainly in the ex-
perimental group; while no significant effects between
groups of DHA diet supplementation were observed.
In order to evaluate the participation of NFκβ activa-
tion in the response to LPS-stimulation and to acute
exercise, active NFκβ levels were determined in PBMCs
(Fig. 3). Active NFκβ levels significantly increased about
20 % respect to the basal value after acute exercise. Basal
PBMC incubation with LPS induced a significant in-
crease of 27 % and 35 % in NFκβ activation at 37 °C and
39.5 °C, respectively.
The effects of acute exercise and DHA diet supple-
mentation on the expression of inflammatory and anti-
inflammatory genes, and COX-1 and COX-2 protein
levels in PBMCs were determined (Table 3). No signifi-
cant changes were observed in the expression of any of
the evaluated genes due to acute exercise or DHA diet
supplementation. Neither acute exercise nor DHA diet
supplementation altered COX-1 protein levels in PBMCs
(Fig. 2). COX-2 protein levels in PBMCs of the experi-
mental group were significantly higher (about 2 times)
than in the placebo group in both basal and post-
exercise conditions; although no effects were evidenced
due to the acute exercise.
Discussion
Effects on plasma prostaglandin levels
PGs are relatively transient molecules with a half-life of
only seconds to minutes, and they work in an autocrine
and paracrine approach through specific receptors [38].
Despite this signalling role and short half-life, basal
plasma levels of PGE1 and PGE2 observed in soccer
players are relatively high. Both molecules show similar
values to those of untrained male university students
[16], higher than those of ironman sportsmen [1], and
lower than post-menopausal or young women [9]. Regu-
lar training for 8 weeks practically duplicated the basal
plasma levels of PGE1, but did not affect basal plasma
levels of PGE2. Treatments with PEG1 are used to ameli-
orate several diseases related to ischemia-reperfusion
[11]. In these studies, PGE1 treatment induced vasodila-
tation, inhibited platelet and leukocyte aggregation and
decreased oedema formation during reperfusion. The
dose of PGE1 used in these treatments increased plasma
PGE1 levels up to values similar to the basal plasma
PGE1 levels observed in soccer players after a training
season. The anti-inflammatory and health effects of
regular exercise [25, 29] could be related to increasing
plasma basal PGE1 levels, taking into account the anti-
inflammatory and vasodilator role of PGE1 [11, 39].
There are several possible origins of plasma PGs as a
Table 1 Effects of acute exercise and DHA diet supplementation on lipid mediator PBMCs-stimulated production rates
Basal Post-exercise ANOVA
S E SxE Fd
PGE1 (pg/h 106 cells) Placebo 51,3 ± 8,19 159 ± 25b .000 (F = 12.32) .002 (F = 25.786) .102 (F = 2.917) (3, 22)
Experimental 22,6 ± 6,47 76,2 ± 11,1ba
PGE2 (pg/h 106 cells) Placebo 263 ± 51,7 615 ± 114a .000 (F = 11.07) .003 (F = 22.787) .813 (F = .057) (3, 22)
Experimental 46,5 ± 14,7b 365 ± 40,5ab
RvD1 (pg/h 106 cells) Placebo 4.24 ± 0.74 7.24 ± 1,69 .956 (F = .003) .007 (F = 8.949) .0668 (F = .189) (3, 22)
Experimental 3.79 ± 0,39 7.81 ± 1,11b
Statistical analysis: Two-way ANOVA, p < 0.05., (S) Significant effect of Supplementation, (E) Significant effect of Acute Exercise, (ExS) Significant interaction between
both factors. One-way ANOVA, p < 0.05. (a) Significant differences between Placebo and Experimental groups, (b) Significant differences between Basal and Post-exercise.
When interaction exists between different groups, different letters reveal significant differences. Results are the mean ± SEM. Fd means Freedom degree
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result of the ubiquitous presence of COX enzymes, in-
cluding muscle, immune cells and platelets; therefore
muscle could be a source of PGs during exercise [38].
Regular exercise training per se influences the phospho-
lipid fatty acid composition of muscle membranes, but
has no effect on the composition of fatty acids stored in
triacylglycerol within the muscle [15]. A training season
was able to induce changes in the muscle phospholipid
composition in such a way as to enhance the capabilities
to PGE1 synthesis, in accordance with the increased
plasma PGE1 levels present after 8 weeks of training.
The different pattern for plasma PGE1 and PGE2 in re-
sponse to training and DHA diet supplementation is not
surprising, given the different biosynthesis pathways of
these two PGs [30]. PGE2 is synthesized from AA (C20:4
Δ5, 8, 11,14) [30], whereas PGE1 is synthesized from
dihomo-γ-linolenic acid (DGLA) (C20:3 Δ8,11,14), a
precursor of AA [30]. The relative differences of plasma
PGE2 versus PGEl levels is not merely a function of the
relative abundance of AA versus DGLA in tissues, but
could also be related to the different cellular metabolism
of these two fatty acids. Chronic exercise induces
changes in the enzyme activities related to eicosanoid
metabolism [26]; elongase activity increases but Δ5- and
Δ9-desaturase activities have no consistent changes at-
tributed to chronic exercise [26], although Δ5-desaturase
was found to be generally lower in muscles of trained
rats [14]. Due to the limited activity of Δ5-desaturase,
most DGLA is inserted into membrane phospholipids at
the same C-2 position as for AA [30]. This picture is in
accordance with the effects of a training season on basal
plasma PGE1 levels enhancing DGLA availability in
muscle phospholipids, in order to facilitate PGE1 synthe-
sis via an increase in COX-1 and COX-2 muscle activ-
ities. It is also in accordance with a lack of effects of
exercise on the fatty acid composition of muscle lipids
Table 2 Effects of LPS-stimulation, DHA diet supplementation and exercise on cytokine production rate by PBMCs
Basal Post-exercise ANOVA
NO LPS LPS NO LPS LPS
IL1β (pg/h 106 cells) Placebo 6.22 ± 1.46 16.3 ± 4.79$ 6.68 ± 1.51 21.1 ± 7.34$ A (.002)
(F = 10.673)
Experimental 9.35 ± 2.24 17.6 ± 6.28$ 8.34 ± 2.19 21.7 ± 8.07$ Fd (7,41)
MCP1 (pg/h 106 cells) Placebo 32.1 ± 9.79 36.1 ± 4.07 36.2 ± 6.14 45.4 ± 3.87 E(.002)
(F = 10.437)
Experimental 22.7 ± 5.31 29.6 ± 4.98 49.6 ± 4.73# 38.3 ± 3.81 Fd (7,41)
Statistical analysis: Two-way ANOVA, p < 0.05. S, Supplementation effect; A, LPS-stimulation effect, E, Exercise effect, SxA, interaction between Supplementation
and LPS-stimulation effects, SxE, interaction between Supplementation and Exercise effects, ExA, interaction between Exercise and LPS activation effects, AxExS,
interaction between effects of three factors. *Differences between Placebo and experimental groups; #difference between Basal and Post-exercise conditions
p; $differences between NO LPS-stimulated and LPS-stimulated groups. When interaction exists between different groups, different letters reveal significant
differences. Results are the mean ± SEM. Fd means Freedom degree
Fig. 3 Effects of LPS stimulation, temperature and acute exercise on NFκβ activation in PBMCs. Statistical analysis: Two-way ANOVA, p < 0.05. (E)
Significant effect of acute exercise, (A) Significant effect of LPS activation. One-way ANOVA, p < 0.05. (*) Significant differences between Basal and
Post-exercise, (#) significant differences between No-stimulated PBMCs and LPS-stimulated PBMCs. When interaction exists between different
factors, different letters reveal significant differences between groups. Results are the mean ± SEM
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reported by a nutritional intervention [26], because no
effects of DHA diet supplementation are observed on
the plasma levels of PGE1.
Acute exercise increases intramuscular PGE2 levels
[17], and also increases or does not affect PGE2 plasma
levels [9], which are attributed to muscle PGE2 produc-
tion. Neither DHA diet supplementation nor acute exer-
cise altered. PGE2 plasma levels, but these two factors
interact resulting in a significant increase in plasma
PGE2 levels after acute exercise in the experimental
group. PGE2 has pro-inflammatory or anti-inflammatory
effects depending on location: it enhances LTB4-
mediated neutrophil extravasation and tissue injury, but
it inhibits the NFκβ signalling pathway via the EP4 re-
ceptor, the LPS-induced IL6 release [26], and plays a
critical role in the initiation of lipid mediator class
switching [32]. PGE2 has been evidenced to suppress
lymphocyte proliferation and natural killer cell activity,
and to inhibit the production of TNFα, IL1, IL6, IL2 and
IFNγ [4]. Acute exercise and DHA diet supplementation
have synergistic effects against inflammation by enhan-
cing PGE2 levels in plasma. These results could reinforce
the idea that practising regular exercise results in health
benefits and reduces the risk of inflammation related
diseases [25].
Effects on PBMC capabilities to produce lipid mediators
and cytokines
It is well established that dietary ω-3 PUFA alters the
fatty acid composition of immune cells [36]. This altered
fatty acid composition could affect immune cell function
[6, 7] and the capability to produce cytokines and lipid
mediators. Similarly, training per se alters the fatty acid
composition of phospholipids and enzyme activities of
the eicosanoid metabolism [26]. Protein levels of COX-1
and COX-2 significantly increased in PBMCs after
8 weeks of a training season, mainly in the DHA supple-
mented group. In addition, this is the first time that an
enhancing effect of DHA diet supplementation on COX-
2 levels has been described in PBMCs. This could indi-
cate greater capabilities of PBMCs after training and
after acute exercise in the DHA supplemented group to
transform DGLA into PGE1 or AA into PGE2, which in
fact could increase basal plasma PGE1 and PGE2 levels;
however, the changes in PGE1 and PGE2 plasma levels
are not consistent with these pictures. This suggests that
PBMCs are not responsible for plasma PGE1 and PGE2
levels, even after acute exercise. COX-2 protein levels
were significantly higher in the DHA diet supplemented
group than in the placebo group, both in basal and post-
exercise conditions. These results are in accordance with
previous studies, in which an increase in both COX2
activity and protein levels was observed after resistance
exercise, and this increase was maintained among 24 h
[8]. The COX-2 isoform is inducible and is involved in
febrile and inflammatory responses [38], whereas the
COX-1 isoform is constitutively expressed in most cells
and catalyzes the production of PGs involved in homeo-
static control and cell maintenance. Synergistic effects of
DHA diet supplementation and acute exercise on PBMC
COX-2 levels are not reflected in the rate of PGE1 and
PGE2 production by LPS-stimulated PBMCs. It seems
that increased levels of COX-2 have no functional conse-
quences, because DHA diet supplementation decreases
the production rate of PGE1 and PGE2 by LPS-
stimulated PBMCs. Discordances between COX protein
levels and COX activity have been previously described
[8]. Acute exercise transiently increased COX-1 activity
in muscle independently of COX-1 protein levels; in
contrast, both COX-2 activity and protein levels were
Table 3 Effects of DHA diet supplementation and exercise on PBMCs gene expression
Basal Post-exercise ANOVA
S E SxE Fd
NFκβ (AU) Placebo 1.00 ± 0.22 1.21 ± 0.31 .576 (f = .373) .369 (f = .142) .906 (f = .006) (3,42)
Experimental 1.33 ± 0.33 1.46 ± 0.33
COX-2 (AU) Placebo 1.00 ± 0.28 1.99 ± 0.86 .355 (f = .026) .726 (f = .592) .513 (f = .142) (3,42)
Experimental 1.46 ± 0.45 1.80 ± 0.51
15-LOX2 (AU) Placebo 1.00 ± 0.37 1.43 ± 0.76 .402 (f = .717) .973 (f = .001) .983 (f = .000) (3,45)
Experimental 1.03 ± 0.30 1.43 ± 0.43
5-LOX (AU) Placebo 1.00 ± 0.28 1.10 ± 0.42 .694 (f = .109) .742 (f = .157) .956 (f = .003) (3,52)
Experimental 0.89 ± 0.21 1.02 ± 0.18
IL1β (AU) Placebo 1.00 ± 0.34 0.84 ± 0.17 .906 (f = .000) .998 (f = .014) .496 (f = .472) (3,42)
Experimental 0.80 ± 0.22 1.03 ± 0.29
Statistical analysis: Two-way ANOVA. (S) Significant effect of supplementation, (E) Significant effect of exercise, (SxE) Significant interaction between both factors.
(#)Significant differences between Placebo and Experimental groups. (*)Significant differences between the Pre-exercise and Post-exercise. p < 0.05. When interaction
exists between different groups, different letters reveal significant differences. Results are the mean ± SEM. Fd means Freedom degree. AU means arbitrary units referred
to Pre-exercise Placebo values
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elevated with exercise and this rise persists until at least
24 h after resistance exercise [8]. In contrast, DHA diet
supplementation did not alter gene expression of NFκβ,
COX-2, 15-LOX2, IL1β or 5-LOX in PBMCs, even after
acute exercise.
LPS-stimulated PBMCs also synthesize RvD1. Rvs are
lipid mediators produced from ω-3 PUFA such as EPA
(Resolvin E) and DHA (Resolvin D) [33]. RvD1 is pro-
duced from DHA through a pathway initiated by COX-2
[33, 34]. Oil fish diet supplementation has been demon-
strated to increase leucocyte capabilities to produce Rvs
[33]. RvD1 has pro-resolving and anti-inflammatory
properties by inhibiting trans-endothelial migration of
neutrophils, preventing their infiltration into sites of in-
flammation and inhibiting IL1β production [33, 34]. The
RvD1 production rate by LPS-stimulated PBMCs was
significantly increased after exercise, mainly in the DHA
supplemented group. Rvs are synthesized by immune
cells after initiation of inflammation in order to contrib-
ute to its complete resolution and returning to homeo-
stasis [32]. These results are in accordance with previous
studies showing an increase in RvD1 serum levels after
acute exercise [22], which could be related in part to the
anti-inflammatory effects of regular exercise [25]. LPS-
stimulated PBMCs simulate the effects of an infection.
In self-limited Escherchia coli infections, resolution pro-
grams were activated in mice, and RvD1 and RvD5 were
elevated [10] in accordance with the effects of LPS acti-
vation on RVD1 production rate by PBMCs. The greater
capabilities to produce RVD1 by LPS-stimulated PBMCs
at post-exercise respect to basal could indicate that post-
exercise circulating immune cells are switching in order
to resolve inflammation to a greater extent than basal
samples. More studies are needed to assess whether
other lipid mediators influence the anti-inflammatory
effects associated with physical exercise.
LPS stimulates PBMC basal production rate of cyto-
kines such as IL6, IL8, and TNFα [6, 7]. LPS links to
TLR4 by activating the NFκβ pathway and inducing an
inflammatory response [27], which was evidenced by in-
creased NFκβ activation after LPS-stimulation of PBMCs
at 37 °C and 39.5 °C and increased basal rate of IL1b
production. Acute exercise also increased active NFκβ in
PBMCs, but it was in parallel with a lack of acute exer-
cise effects on the expression of inflammatory genes.
Active NFκβ translocates to the nucleus allowing the
expression of inflammatory genes but additional stimu-
lus must be operative to enhance the expression of
NFκβ, COX-2, 15-LOX2, IL1β and 5-LOX in PBMCs
after acute exercise. Acute exercise increased active
NFκβ levels priming PBMCs for inflammatory response.
Acute exercise increased PBMC production rate of
MCP1 and also primes PBMCs to respond to LPS-
stimulation in order to enhance their PGE1, PGE2, RvD1
and MCP1 production. These results are in accordance
with increased levels of TLR4 found in PBMCs after
acute exercise, and with the higher rate of cytokine pro-
duction after LPS-stimulation of post-exercise PBMCs
[6, 7]. DHA diet supplementation attenuated the response
of acute exercise to stimulation of PBMCs with LPS. The
anti-inflammatory effects of DHA-diet supplementation
have been described in previous studies [6, 7, 36]. DHA-
supplementation attenuates the effects of acute exercise
by increasing TLR4 levels in PBMCs [6, 7]. ω-3 PUFA can
interfere with TLR4 activation by LPS; this process inhibits
signalling components downstream from TLR4 but can
also directly prevent NFκβ activation by impeding I-κβ
phosphorylation and therefore prevent NFκβ translocation
into the nucleus [27].
Conclusion
In summary, regular training promotes systemic anti-
inflammatory and vasodilator effects by increasing PGE1.
Acute exercise and DHA diet supplementation act syn-
ergistically by increasing plasma PGE2 and also with
anti-inflammatory effects. Acute exercise primes PBMCs
to enhance PGE1, PGE2 and RvD1 production rates in
response to LPS, with a higher anti-inflammatory and
resolute profile for PBMCs after exercise. The differ-
ences between eicosanoid production by PBMCs and
plasma eicosanoid levels reinforce the idea that PBMCs
are not the main contributors to plasma PGE2 and PGE1
after acute exercise.
Finally, prescription of regular exercise, similar to foot-
ball training, could produce anti-inflammatory effects
associated to an increase in PGE1 and PGE2 levels. Fur-
thermore, the enhancement of muscular prostaglandins
synthesis, probably trough exercise, could subserve these
anti-inflammatory and vasodilator effects. In addition,
acute exercise and DHA supplementation can act syner-
gistically in the induction of anti-inflammatory response,
but also both factors may reduce the inflammatory
response induced by pathogen-associated molecular
pattern (PAMPs) as LPS.
Limitation of the study
The experimental procedure was designed to perform
exercise at intensity higher than 70 % VO2max for more
than 50 % duration of the session in order to induce an
oxidative stress situation. These conditions were
followed by all participants in the study; however, we did
not realized any quantification of the effort using port-
able metabolic carts, activity monitors or video analysis
to confirm energy expenditure or movement pattern,
and this fact could be the main limitation of the study.
Another limitation was low number of participant in
each group. Twenty-two athletes, eleven in each group,
participate in the trail at the beginning of the study;
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unfortunately, six athletes left the football team during
the trial to join the first and professional team and one
broke the anterior cruciate ligament of the knee.
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